Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Iron Deficiency Anemia Associated with Hearing Loss

By LabMedica International staff writers
Posted on 10 Jan 2017
In a new study assessing medical records of over 300,000 adults, researchers found a significant positive association between iron deficiency anemia (IDA) and hearing loss, including sensorineural hearing loss (SNHL).

Because IDA is a common and easily correctable condition, further understanding of the association between IDA and all types of hearing loss may help to open new possibilities for early identification and appropriate treatment. More...
For this study, Kathleen M. Schieffer, BS, of Pennsylvania State University College of Medicine (Hershey, PA, USA), and colleagues investigated the potential association using data obtained from deidentified electronic medical records from the Penn State Milton S. Hershey Medical Center (Hershey, PA, USA). IDA was determined by low hemoglobin and ferritin levels for age and sex in 305,339 adults ages 21-90 years.

Of the patients in the study population, 43% were men; average age was 50 years. There was a 0.7% prevalence of IDA and a 1.6% prevalence of “combined hearing loss” (defined as any combination of: conductive hearing loss [hearing loss due to problems with the bones of the middle ear], sensorineural hearing loss [SNHL; when there is damage to the cochlea or to the nerve pathways from the inner ear to the brain], deafness, and unspecified hearing loss).

Both sensorineural hearing loss (present in 1.1% of individuals with IDA) and combined hearing loss (present in 3.4%) were significantly associated with IDA. Analysis confirmed increased odds of SNHL and combined hearing loss among adults with IDA.

“An association exists between IDA in adults and hearing loss. The next steps are to better understand this correlation and whether promptly diagnosing and treating IDA may positively affect the overall health status of adults with hearing loss,” the researchers wrote.

The study, by Schieffer KM et al, was published online December 29, 2016, in the journal JAMA Otolaryngology–Head & Neck Surgery.

Related Links:
Pennsylvania State University College of Medicine


New
Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.